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The title compound, C15H14ClF3N4, was synthesized from 3,6-
dichloropyridazine and 1-[3-(triﬂuoromethyl)phenyl]piper-
azine. The piperazine ring is ﬂanked by 3-chloropyridazine
and 3-triﬂuoromethylphenyl rings and adopts a chair confor-
mation, whereas the 3-chloropyridazine and 3-triﬂuoro-
methylphenyl rings are planar, with maximum deviations of
0.0069 (13) and 0.0133 (14) A ˚ , respectively. The crystal
structure is stabilized by weak intermolecular C—HN
hydrogen-bond interactions.
Related literature
For the synthesis and analgesic and anti-inﬂammatory activity
of pyridazinone and pyridazine derivatives, see: Arslan et al.
(2010); Giri & Mukhopadhyay (1998); Boissier et al. (1963);
Gokce et al. (2001, 2004, 2005, 2009); Sahin et al. (2004);
Dundar et al. (2007). For general background to pyrazolone
derivatives, see: Amir et al. (2008); Banoglu et al. (2004). For
puckering parameters, see: Cremer & Pople (1975).
Experimental
Crystal data
C15H14ClF3N4 Mr = 342.75
Monoclinic, P21=c
a = 9.461 (6) A ˚
b = 6.557 (4) A ˚
c = 24.123 (16) A ˚
  = 99.890 (9)
V = 1474.1 (16) A ˚ 3
Z =4
Mo K  radiation
  = 0.30 mm
1
T = 173 K






Tmin = 0.888, Tmax = 0.932
19935 measured reﬂections
3385 independent reﬂections












 max = 0.32 e A ˚ 3
 min = 0.23 e A ˚ 3
Table 1
Hydrogen-bond geometry (A ˚ , ).
D—HAD —H HAD AD —HA
C11—H11BN4
i 0.99 2.69 3.628 (2) 158
Symmetry code: (i) x;y  1;z.
Data collection: APEX2 (Bruker, 2008); cell reﬁnement: SAINT
(Bruker, 2008); data reduction: SAINT; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
SHELXTL (Sheldrick, 2008); software used to prepare material for
publication: SHELXTL.
Supplementary data and ﬁgures for this paper are available from the
IUCr electronic archives (Reference: HG2643).
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3-Chloro-6-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}pyridazine
H. Arslan, S. Utku, K. I. Hardcastle, M. Gökçe and S. Lense
Comment
It is known that some pyrazolone derivatives like oxyphenbutazone, dipyrone, antipyrine and phenylbutazone are used
primarily for their anti-inflammatory, antipyretic and analgesic activities, but several side effects have limited the clinical
use of these drugs such as some of pyrazolone derivatives are toxic and carcinogenicin animals, clastogenic in somatic and
germ cells of male mice, and also weakly mutagenic in Salmonella strain TA100 in presence of rat liver homogenate. In
addition, some of pyrazolone derivatives induce peptic ulcer, hypersensitivity reaction, hepatitis, nephritis and bone marrow
suppression (Giri & Mukhopadhyay, 1998).
Pyridazinone derivatives are structurally related to pyrazolone derivatives (Gokce et al., 2009). Many pyridazinone de-
rivatives have been reported as analgesic and anti-inflammatory agents without gastrointestinal side effect (Amir et al.,
2008, Banoglu et al., 2004, Gokce et al., 2009). This is agreement with in our experience in the pyridazinone field. (Dundar
et al., 2007; Gokce et al., 2001, 2004, 2005, 2009; Sahin et al., 2004).
Recently, our research has focussed on the chemical, physical and biologycal properties of pyridazinone derivat-
ives (Gokce et al., 2009, Arslan et al., 2010). The title compound, 3-chloro-6-{4-[3-(trifluoromethyl)phenyl]piperazin-1-
yl}pyridazine, I, Scheme 1, is an example and in this article, we report on the crystal structure of the title compound, Figure 1.
The molecular structure of I consists of 3-chloropyridazine and 3-trifluoromethylphenyl arms connected to a piperazine
ring. The 3-chloropyridazine and 3-trifluoromethylphenyl rings are planar with a maximum deviation of -0.0069 (13) Å for
atom C7 and -0.0133 (14) Å for atom C3. The dihedral angle between these two rings is 18.77 (6) °. The piperazine ring
adopts a chair conformation. This is confirmed by the puckering parameters q2 = 0.0107 (14) Å, q3= 0.5479 (13) Å, QT =
0.5480 (13) Å, θ = 1.05 (15) ° and φ= 85 (7) ° (Cremer & Pople, 1975).
The conformations of the 3-chloropyridazine and 3-trifluoromethylphenyl rings are best described by the torsion angles
of 159.40 (11) ° and -165.62 (11) ° for C7—N2—C6—C5 and C4—N1—C12—C11, respectively; thus they adopt + anti-
periplanar and - antiperiplanar conformations, respectively.
The crystal packing is dominated by weak intermolecular C11—H11B···N4 (x, y-1, z) hydrogen bonds, with H···N = 2.69
Å and a C—H···N angle of 150 ° (Figure 2).
Experimental
A mixture of 3,6-dichloropyridazine, II, (1.7 mol) and 1-[3-(trifluoromethyl)phenyl]piperazine, III, (2.0 mol) in ethanol (10
ml) was heated under reflux for 4 hours after which the mixture was cooled to room temperature (Figure 3) (Boissier et
al. (1963)). The resulting crude precipitate was filtered off and purified by repeated washing with small portions of cold
ethanol. The precipitate formed was crystallized from CH2Cl2: ethanol (5:10 ml) to give the compound, 3-chloro-6-{4-
[3-(trifluoromethyl)phenyl]piperazin-1-yl}pyridazine, I, as white crystals. Yields: 0.485 g, 83%. M.p.: 167 °C. 1H-NMRsupplementary materials
sup-2
(DMSO-d6) δ: 7.56-7.54 (d, 1H, pyridazin), 7.46-7.40 (m, 2H, phenyl), 7.28-7.21 (m, 1H, phenyl), 7.14-7.12 (d, 1H, phenyl),
7.09-7.07 (d, 1H, pyridazin), 3.74-3.71 (t, 2H, piperazine), 3.45-3.43 (t, 2H, piperazine), 3.19-3.17 (t, 4H, piperazine). MS
(EI) m/z: 343 (M+). Anal. Calc. for C15H14N4ClF3: C, 52.56; H, 4.12; N, 16.35%. Found: C, 52.61; H, 4.09; N, 16.40%.
Refinement
The H atoms were positioned geometrically and allowed to ride on their parent atoms, with C—H distances of 0.95 Å (CH)
or 0.99 Å (CH2), and with Uiso(H) = 1.2Ueq of the parent atoms.
Figures
Fig. 1. The molecular structure of (I), showing ellipsoids at the 50% probability level.
Fig. 2. The molecular packing of (I). The hydrogen bonds are shown as dashed lines.
Fig. 3. Synthesis of the title compound.
3-Chloro-6-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}pyridazine
Crystal data
C15H14ClF3N4 F(000) = 704
Mr = 342.75 Dx = 1.544 Mg m−3
Monoclinic, P21/c Mo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybc Cell parameters from 7857 reflections
a = 9.461 (6) Å θ = 2.2–29.7°
b = 6.557 (4) Å µ = 0.30 mm−1
c = 24.123 (16) Å T = 173 K
β = 99.890 (9)° Block, colourless




diffractometer 3385 independent reflections
Radiation source: fine-focus sealed tube 2781 reflections with I > 2σ(I)supplementary materials
sup-3
graphite Rint = 0.065
φ and ω scans θmax = 27.5°, θmin = 1.7°
Absorption correction: multi-scan
(SADABS; Bruker, 2008) h = −12→12
Tmin = 0.888, Tmax = 0.932 k = −8→8
19935 measured reflections l = −31→31
Refinement
Refinement on F2 Primary atom site location: structure-invariant direct
methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.036
Hydrogen site location: inferred from neighbouring
sites
wR(F2) = 0.101 H-atom parameters constrained
S = 1.06
w = 1/[σ2(Fo
2) + (0.0589P)2 + 0.1216P]
where P = (Fo
2 + 2Fc
2)/3
3385 reflections (Δ/σ)max = 0.005
208 parameters Δρmax = 0.32 e Å−3
0 restraints Δρmin = −0.23 e Å−3
Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The
cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds
in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used
for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-
factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large
as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
C1 1.35124 (16) 0.4693 (2) 0.76675 (6) 0.0301 (3)
C2 1.23214 (15) 0.35744 (19) 0.78778 (5) 0.0228 (3)
C3 1.15571 (14) 0.45817 (19) 0.82401 (5) 0.0212 (3)
H3 1.1811 0.5939 0.8354 0.025*
C4 1.04104 (14) 0.36134 (18) 0.84400 (5) 0.0194 (3)
C5 1.01095 (15) 0.65546 (17) 0.90409 (6) 0.0235 (3)
H5A 1.0563 0.7374 0.8775 0.028*
H5B 1.0856 0.6219 0.9368 0.028*
C6 0.89367 (15) 0.78043 (18) 0.92372 (6) 0.0241 (3)
H6A 0.9364 0.9031 0.9439 0.029*
H6B 0.8240 0.8262 0.8906 0.029*
C7 0.74380 (13) 0.76537 (18) 0.99646 (5) 0.0186 (3)supplementary materials
sup-4
C8 0.62135 (14) 0.9883 (2) 1.06758 (5) 0.0220 (3)
C9 0.60062 (14) 0.7770 (2) 1.06879 (5) 0.0236 (3)
H6 0.5458 0.7163 1.0939 0.028*
C10 0.66253 (14) 0.66193 (19) 1.03229 (5) 0.0221 (3)
H10 0.6517 0.5179 1.0309 0.027*
C11 0.76124 (14) 0.47012 (18) 0.93414 (6) 0.0223 (3)
H11A 0.6846 0.5022 0.9019 0.027*
H11B 0.7183 0.3881 0.9614 0.027*
C12 0.87797 (15) 0.34660 (18) 0.91356 (6) 0.0226 (3)
H12A 0.9476 0.2987 0.9464 0.027*
H12B 0.8344 0.2250 0.8930 0.027*
C13 1.01216 (15) 0.15733 (18) 0.82706 (5) 0.0238 (3)
H13 0.9365 0.0862 0.8399 0.029*
C14 1.09205 (16) 0.05852 (19) 0.79199 (5) 0.0277 (3)
H14 1.0708 −0.0796 0.7819 0.033*
C15 1.20215 (16) 0.1564 (2) 0.77128 (6) 0.0268 (3)
H15 1.2552 0.0886 0.7467 0.032*
Cl1 0.54631 (4) 1.14481 (6) 1.113190 (14) 0.03333 (13)
F1 1.47712 (10) 0.45600 (17) 0.80245 (4) 0.0510 (3)
F2 1.37526 (11) 0.39838 (16) 0.71726 (4) 0.0517 (3)
F3 1.32478 (10) 0.66983 (13) 0.75974 (4) 0.0438 (3)
N1 0.95396 (11) 0.46588 (15) 0.87639 (4) 0.0201 (2)
N2 0.81888 (12) 0.66056 (15) 0.96101 (4) 0.0201 (2)
N3 0.75776 (12) 0.96974 (15) 0.99729 (4) 0.0233 (3)
N4 0.69511 (12) 1.08204 (16) 1.03382 (5) 0.0248 (3)
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
C1 0.0290 (8) 0.0347 (7) 0.0294 (7) −0.0006 (6) 0.0132 (6) −0.0075 (6)
C2 0.0230 (7) 0.0259 (6) 0.0203 (6) 0.0020 (5) 0.0054 (5) −0.0013 (5)
C3 0.0239 (7) 0.0189 (6) 0.0219 (6) −0.0001 (5) 0.0065 (5) −0.0028 (5)
C4 0.0236 (7) 0.0184 (6) 0.0163 (6) 0.0026 (5) 0.0040 (5) 0.0014 (4)
C5 0.0269 (7) 0.0156 (6) 0.0314 (7) −0.0049 (5) 0.0147 (6) −0.0026 (5)
C6 0.0318 (8) 0.0149 (5) 0.0298 (7) −0.0027 (5) 0.0175 (6) 0.0001 (5)
C7 0.0176 (7) 0.0194 (6) 0.0189 (6) −0.0007 (5) 0.0032 (5) 0.0011 (4)
C8 0.0196 (7) 0.0285 (6) 0.0181 (6) 0.0016 (5) 0.0038 (5) −0.0036 (5)
C9 0.0201 (7) 0.0307 (7) 0.0211 (6) −0.0022 (5) 0.0063 (5) 0.0041 (5)
C10 0.0225 (7) 0.0202 (6) 0.0244 (6) −0.0025 (5) 0.0063 (5) 0.0031 (5)
C11 0.0231 (7) 0.0182 (6) 0.0274 (7) −0.0055 (5) 0.0094 (5) −0.0023 (5)
C12 0.0281 (8) 0.0144 (5) 0.0278 (7) −0.0037 (5) 0.0118 (6) −0.0007 (5)
C13 0.0314 (8) 0.0186 (6) 0.0226 (6) −0.0027 (5) 0.0081 (6) 0.0012 (5)
C14 0.0415 (9) 0.0184 (6) 0.0237 (6) 0.0011 (6) 0.0073 (6) −0.0026 (5)
C15 0.0324 (8) 0.0258 (7) 0.0237 (7) 0.0055 (5) 0.0089 (6) −0.0042 (5)
Cl1 0.0347 (2) 0.0404 (2) 0.0277 (2) 0.00403 (15) 0.01307 (16) −0.00988 (14)
F1 0.0271 (6) 0.0704 (7) 0.0556 (6) −0.0063 (5) 0.0077 (5) 0.0012 (5)
F2 0.0615 (7) 0.0616 (6) 0.0419 (6) −0.0158 (5) 0.0369 (5) −0.0197 (5)
F3 0.0458 (6) 0.0321 (5) 0.0617 (6) −0.0037 (4) 0.0324 (5) 0.0035 (4)supplementary materials
sup-5
N1 0.0250 (6) 0.0148 (5) 0.0228 (5) −0.0022 (4) 0.0107 (5) −0.0010 (4)
N2 0.0239 (6) 0.0144 (5) 0.0246 (6) −0.0032 (4) 0.0115 (5) 0.0001 (4)
N3 0.0279 (7) 0.0186 (5) 0.0261 (6) −0.0026 (4) 0.0121 (5) −0.0027 (4)
N4 0.0279 (7) 0.0225 (5) 0.0258 (6) −0.0017 (5) 0.0096 (5) −0.0057 (4)
Geometric parameters (Å, °)
C1—F2 1.3364 (16) C8—N4 1.3129 (17)
C1—F3 1.3439 (18) C8—C9 1.400 (2)
C1—F1 1.3472 (18) C8—Cl1 1.7425 (14)
C1—C2 1.504 (2) C9—C10 1.3654 (18)
C2—C15 1.3920 (19) C9—H6 0.9500
C2—C3 1.3928 (18) C10—H10 0.9500
C3—C4 1.4114 (18) C11—N2 1.4681 (17)
C3—H3 0.9500 C11—C12 1.5199 (18)
C4—N1 1.4073 (16) C11—H11A 0.9900
C4—C13 1.4115 (18) C11—H11B 0.9900
C5—N1 1.4691 (17) C12—N1 1.4676 (16)
C5—C6 1.5190 (18) C12—H12A 0.9900
C5—H5A 0.9900 C12—H12B 0.9900
C5—H5B 0.9900 C13—C14 1.3878 (19)
C6—N2 1.4650 (16) C13—H13 0.9500
C6—H6A 0.9900 C14—C15 1.388 (2)
C6—H6B 0.9900 C14—H14 0.9500
C7—N3 1.3462 (17) C15—H15 0.9500
C7—N2 1.3845 (16) N3—N4 1.3600 (15)
C7—C10 1.4236 (17)
F2—C1—F3 106.53 (12) C10—C9—H6 121.4
F2—C1—F1 106.34 (12) C8—C9—H6 121.4
F3—C1—F1 105.59 (12) C9—C10—C7 117.68 (12)
F2—C1—C2 112.59 (12) C9—C10—H10 121.2
F3—C1—C2 112.66 (11) C7—C10—H10 121.2
F1—C1—C2 112.60 (13) N2—C11—C12 111.21 (11)
C15—C2—C3 121.75 (12) N2—C11—H11A 109.4
C15—C2—C1 119.53 (12) C12—C11—H11A 109.4
C3—C2—C1 118.72 (12) N2—C11—H11B 109.4
C2—C3—C4 120.89 (12) C12—C11—H11B 109.4
C2—C3—H3 119.6 H11A—C11—H11B 108.0
C4—C3—H3 119.6 N1—C12—C11 112.04 (11)
N1—C4—C13 121.30 (11) N1—C12—H12A 109.2
N1—C4—C3 121.89 (11) C11—C12—H12A 109.2
C13—C4—C3 116.70 (11) N1—C12—H12B 109.2
N1—C5—C6 111.56 (11) C11—C12—H12B 109.2
N1—C5—H5A 109.3 H12A—C12—H12B 107.9
C6—C5—H5A 109.3 C14—C13—C4 121.34 (12)
N1—C5—H5B 109.3 C14—C13—H13 119.3
C6—C5—H5B 109.3 C4—C13—H13 119.3
H5A—C5—H5B 108.0 C15—C14—C13 121.65 (12)
N2—C6—C5 110.97 (11) C15—C14—H14 119.2supplementary materials
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N2—C6—H6A 109.4 C13—C14—H14 119.2
C5—C6—H6A 109.4 C14—C15—C2 117.62 (12)
N2—C6—H6B 109.4 C14—C15—H15 121.2
C5—C6—H6B 109.4 C2—C15—H15 121.2
H6A—C6—H6B 108.0 C4—N1—C12 118.34 (10)
N3—C7—N2 116.34 (10) C4—N1—C5 117.42 (11)
N3—C7—C10 121.81 (11) C12—N1—C5 110.68 (10)
N2—C7—C10 121.77 (12) C7—N2—C6 117.79 (10)
N4—C8—C9 124.58 (11) C7—N2—C11 120.25 (11)
N4—C8—Cl1 115.68 (10) C6—N2—C11 111.53 (10)
C9—C8—Cl1 119.73 (10) C7—N3—N4 119.73 (10)
C10—C9—C8 117.13 (12) C8—N4—N3 119.05 (11)
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
C11—H11B···N4i 0.99 2.69 3.628 (2) 158
Symmetry codes: (i) x, y−1, z.supplementary materials
sup-7
Fig. 1supplementary materials
sup-8
Fig. 2supplementary materials
sup-9
Fig. 3